|
Real-time Estimate
Cboe BZX
04:51:58 11/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 797.72 USD | -1.23% |
|
-5.45% | +3.32% |
| Market Cap | 80.65B 69.36B 65.44B 59.62B 111B 7,711B 112B 779B 300B 3,911B 303B 296B 12,422B | P/E 2026 * |
18.7x | P/E 2027 * | 16x |
|---|---|---|---|---|---|
| Enterprise Value | 73.48B 63.19B 59.62B 54.31B 102B 7,025B 102B 710B 273B 3,563B 276B 270B 11,317B | EV / Sales 2026 * |
4.34x | EV / Sales 2027 * | 3.82x |
| Free-Float |
71.06% | Yield 2026 * |
0.48% | Yield 2027 * | 0.54% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| REGN | Delayed | |
CBOE
| REGN | Real-time | |
|
Mexican S.E.
| REGN * | End-of-day quote | |
|
Xetra
| RGO | End-of-day quote | |
|
Tradegate
| RGO | Real-time | |
|
Boerse Muenchen
| RGO | Real-time | |
|
London S.E.
| 0R2M | Delayed | |
|
Borsa Italiana
| 1REGN | End-of-day quote | |
|
Deutsche Boerse AG
| RGO | Delayed | |
|
Wiener Boerse
| REGN | End-of-day quote | |
|
Börse Stuttgart
| RGO | Delayed | |
|
Lima
| REGNUS | End-of-day quote |
Last Transcript : Regeneron Pharmaceuticals, Inc.
| 1 day | -1.48% | ||
| 1 week | -5.87% | ||
| Current month | -0.64% | ||
| 1 month | -1.74% | ||
| 3 months | +31.97% | ||
| 6 months | +2.85% | ||
| Current year | +2.87% |
| 1 week | 792.9 |  | 841.54 |
| 1 month | 779.08 | | 859.34 |
| Current year | 591.52 | | 859.34 |
| 1 year | 541 | | 859.34 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 01/01/2001 | |
| Chief Executive Officer | 73 | 08/01/1988 | |
| Director of Finance/CFO | 55 | 05/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 09/06/2023 | |
Michael Brown
BRD | Director/Board Member | 85 | 01/06/1991 |
Joseph Goldstein
BRD | Director/Board Member | 85 | 01/06/1991 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/9/26 | Sell | Executive/Senior Manager | -1,131 | 0.0011% | ||
| 2/9/26 | Exercice | Director | 1,200 | 0.0012% | ||
| 19/8/26 | Exercice | General Counsel | 33,583 | 0.0326% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.47% | -5.87% | +42.85% | -4.74% | 80.65B | |
| -1.00% | -2.50% | -19.26% | -37.42% | 59.12B | |
| -0.52% | -9.61% | +453.52% | +27.18% | 54.14B | |
| -2.00% | -5.20% | -11.09% | +27.83% | 50.1B | |
| -1.42% | -8.61% | -3.21% | +144.72% | 45.33B | |
| +2.16% | -4.22% | +50.79% | -16.95% | 31.14B | |
| -2.48% | -4.07% | +42.37% | +90.64% | 25.54B | |
| -3.92% | -7.32% | -6.49% | +166.90% | 21.8B | |
| -0.99% | -4.61% | +62.88% | +97.84% | 16.06B | |
| -3.68% | -3.18% | +37.86% | +155.91% | 14.87B | |
| Average | -1.54% | -3.46% | +65.02% | +65.19% | 39.88B | |
| Weighted average by Cap. | -1.33% | -3.72% | +75.89% | +40.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.93B 14.56B 13.73B 12.51B 23.39B 1,618B 23.6B 164B 62.95B 821B 63.56B 62.17B 2,607B | 18.48B 15.9B 15B 13.66B 25.54B 1,767B 25.77B 179B 68.75B 896B 69.41B 67.89B 2,847B |
| Net income | 4.77B 4.11B 3.87B 3.53B 6.6B 456B 6.66B 46.13B 17.75B 231B 17.92B 17.53B 735B | 5.45B 4.68B 4.42B 4.03B 7.52B 521B 7.59B 52.62B 20.25B 264B 20.45B 20B 839B |
| Net Debt | -7.17B -6.17B -5.82B -5.3B -9.91B -686B -10B -69.31B -26.67B -348B -26.93B -26.34B -1,105B | -10.05B -8.65B -8.16B -7.43B -13.89B -961B -14.02B -97.17B -37.4B -488B -37.76B -36.93B -1,549B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/09/26 | USD 797.56 | -1.25% | 223,743 |
| 09/09/26 | USD 807.65 | -0.33% | 621,458 |
| 08/09/26 | USD 810.31 | -2.10% | 556,536 |
| 04/09/26 | USD 827.72 | -1.87% | 561,170 |
| 03/09/26 | USD 843.47 | -1.00% | 496,255 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
